Democrats are on the verge of a sweeping health care achievement that will address one of the country’s most intractable problems: high prescription drug costs. The Senate on Sunday passed a broad climate, tax, and health care package that delivers key pieces of President Joe Biden’s stalled economic agenda. While the legislation is smaller than Democrats’ original hopes last year, the health care provisions alone are what Biden might call a “big f-cking deal.” The bill will allow Medicare for the first time to negotiate with drug makers for lower prescription drug prices, something that governments in many other wealthy countries do and a long-held priority for Democrats.
Similar Stories to How The Inflation Reduction Act Could Lower Your Drug Costs on Bing News
Abigail Abrams, Time
Mon, 08/08/2022 - 1:31pm
Topics: the senate president joe biden s aug vice president kamala harris november aarp ceo jo ann jenkins the house biden&rsquo drug ldquo;this tricia neuman kaiser family congressional budget office cbo west health gallup phelan m ebenhack&mdash apretiree donna weiner oct longwood limit medicare&rsquo paying that s george valentine dallas texas i&rsquo ldquo;it amy niles tackling glen fewkes aarp ldquo;all rep susie lee nevada curbing centers medicaid services kff this republican senators senate republicans obamacare affordable care act the rescue plan rep lee democrats senate biden america house biden inflation reduction act affordable care act medicare ldquo;we aarp house democrat foundation cbo prescription medicare part d fla it pan medicare bill prices medications year negotiate insurance out-of-pocket subsidies passed package price seniors average dollars insulin pieces increase executive high month time provision pharmacy beneficiaries industry vote pharmaceutical years cap million rebates premium private faster change extend legislation significant parliamentarian invest savings class vaccines access hike makers idea process older months apply middle campaign billions spent true day fixed give pays reach lot event leukemia treatment annual rate policy expensive previously experts buy maximum require director
BING NEWS:
- Judge skeptical of government 'price setting' in PhRMA's Medicare drug negotiation lawsuit
Last year, the drug industry trade group sued the government, claiming the program violated the Constitution by giving too much power to federal regulators and imposing excessive fines on companies ...
05/3/2024 - 5:03 am | View Link - Judge Dismisses Challenges on Medicare Drug Negotiation from Bristol Myers Squibb, Johnson & Johnson
A federal judge has dismissed legal challenges to the Medicare negotiation program brought by Bristol Myers Squibb and Johnson & Johnson, ruling that their claims of unconstitutionality are unfounded.
05/3/2024 - 3:55 am | View Link - Inflation Reduction Act's Dirty Little Secret: Largest Premium Increase Ever for Medicare Drug Benefit
When President Biden signed the Inflation Reduction Act in 2022, he promised it would lower Medicare costs for America's seniors. Loaded with the all-too-familiar political rhetoric of "taking it to ...
05/2/2024 - 5:01 pm | View Link - OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of ...
05/1/2024 - 2:09 am | View Link - Potential Effects of the Inflation Reduction Act on Orphan Drug Development
President Biden signed the Inflation Reduction Act (IRA) into law on Aug. 16, 2022, with the goal of reducing health care costs for the government and participants in Medicare and Medicaid programs.
04/30/2024 - 1:00 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more